PAM
IMGN

Panagora Asset Management’s Immunogen Inc IMGN Stock Holding History

Panagora Asset Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-409,658
Closed -$12.1M – 1282
2023
Q4 		$12.1M Sell
409,658
-688,759
-63% -$13.7M 0.07% 200
2023
Q3 		$17.4M Sell
1,098,417
-19,552
-2% -$325K 0.11% 160
2023
Q2 		$21.1M Sell
1,117,969
-99,173
-8% -$1.17M 0.12% 166
2023
Q1 		$4.67M Buy
1,217,142
+145,791
+14% +$621K 0.03% 380
2022
Q4 		$5.31M Sell
1,071,351
-9,657
-0.9% -$52.4K 0.03% 370
2022
Q3 		$5.17M Sell
1,081,008
-80,205
-7% -$423K 0.04% 352
2022
Q2 		$5.22M Sell
1,161,213
-12,642
-1% -$54.9K 0.03% 370
2022
Q1 		$5.59M Buy
1,173,855
+39,385
+3% +$218K 0.03% 389
2021
Q4 		$8.42M Sell
1,134,470
-12,724
-1% -$79.1K 0.04% 320
2021
Q3 		$6.5M Buy
1,147,194
+21,109
+2% +$122K 0.03% 377
2021
Q2 		$7.42M Sell
1,126,085
-86,824
-7% -$606K 0.04% 361
2021
Q1 		$9.82M Sell
1,212,909
-100,168
-8% -$818K 0.06% 312
2020
Q4 		$8.47M Buy
1,313,077
+152,565
+13% +$890K 0.05% 316
2020
Q3 		$4.18M Sell
1,160,512
-668,248
-37% -$2.7M 0.03% 436
2020
Q2 		$8.41M Buy
1,828,760
+228,682
+14% +$973K 0.05% 284
2020
Q1 		$5.46M Sell
1,600,078
-504,139
-24% -$2.2M 0.04% 329
2019
Q4 		$10.7M Buy
2,104,217
+272,132
+15% +$924K 0.05% 318
2019
Q3 		$4.43M Buy
1,832,085
+372,958
+26% +$990K 0.02% 492
2019
Q2 		$3.17M Buy
1,459,127
+81,714
+6% +$193K 0.01% 646
2019
Q1 		$3.73M Buy
1,377,413
+276,376
+25% +$1.2M 0.02% 608
2018
Q4 		$5.29M Buy
1,101,037
+164,249
+18% +$997K 0.02% 449
2018
Q3 		$8.87M Buy
936,788
+33,481
+4% +$322K 0.03% 387
2018
Q2 		$8.79M Buy
903,307
+49,607
+6% +$523K 0.03% 380
2018
Q1 		$8.98M Buy
853,700
+139,633
+20% +$1.38M 0.04% 378
2017
Q4 		$4.58M Sell
714,067
-205,442
-22% -$1.27M 0.02% 578
2017
Q3 		$7.03M Sell
919,509
-633,629
-41% -$4.21M 0.03% 484
2017
Q2 		$11M Buy
1,553,138
+81,375
+6% +$372K 0.04% 382
2017
Q1 		$5.7M Buy
1,471,763
+112,900
+8% +$329K 0.02% 549
2016
Q4 		$2.77M Buy
1,358,863
+518,059
+62% +$1.04M 0.01% 761
2016
Q3 		$2.25M Buy
840,804
+602,649
+253% +$1.75M 0.01% 843
2016
Q2 		$734K Buy
238,155
+228,413
+2,345% +$1.43M ﹤0.01% 1233
2016
Q1 		$83K Buy
+9,742
New +$82.4K ﹤0.01% 1906

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Panagora Asset Management's IMGN Position: Q1 2024 in Review

Panagora Asset Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 409,658 shares — an estimated $12.1M sold.

Panagora Asset Management first reported a position in IMGN in Q1 2016 and held it in 32 quarters. The position peaked at $21.1M in Q2 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Panagora Asset Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Panagora Asset Management sold 409,658 Immunogen Inc shares in Q1 2024, an estimated $12.1M.
  • Panagora Asset Management first reported a position in Immunogen Inc in Q1 2016 and held it in 32 quarters.
  • Panagora Asset Management's Immunogen Inc position peaked at $21.1M in Q2 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Panagora Asset Management's 13F filing for Q1 2024, filed 7 May 2024.